ÁñÁ«ÊÓƵ Network Open
Original Investigation
Infectious Diseases
April 4, 2024
Diya Surie, MD; Katharine A.ÌýYuengling, MPH; Jennifer DeCuir, MD, PhD; Yuwei Zhu, MD; Adam S.ÌýLauring, MD, PhD; Manjusha Gaglani, MBBS; Shekhar Ghamande, MD; Ithan D.ÌýPeltan, MD, MSc; Samuel M.ÌýBrown, MD, MS; Adit A.ÌýGinde, MD, MPH; Amanda Martinez, MPH; Nicholas M.ÌýMohr, MD; Kevin W.ÌýGibbs, MD; David N.ÌýHager, MD, PhD; Harith Ali, MBChB; Matthew E.ÌýPrekker, MD, MPH; Michelle N.ÌýGong, MD, MS; Amira Mohamed, MD; Nicholas J.ÌýJohnson, MD; Vasisht Srinivasan, MD; Jay S.ÌýSteingrub, MD; Aleda M.ÌýLeis, PhD, MS; Akram Khan, MD; Catherine L.ÌýHough, MD; William S.ÌýBender, MD, MPH; Abhijit Duggal, MD, MPH, MSc; Emily E.ÌýBendall, PhD; Jennifer G.ÌýWilson, MD; Nida Qadir, MD; Steven Y.ÌýChang, MD, PhD; Christopher Mallow, MD, MHS; Jennie H.ÌýKwon, DO, MSCI; Matthew C.ÌýExline, MD, MPH; Nathan I.ÌýShapiro, MD, MPH; Cristie Columbus, MD; Ivana A.ÌýVaughn, PhD, MPH; Mayur Ramesh, MD; Jarrod M.ÌýMosier, MD; Basmah Safdar, MD, MSc; Jonathan D.ÌýCasey, MD; H. Keipp Talbot, MD; Todd W.ÌýRice, MD; Natasha Halasa, MD, MPH; James D.ÌýChappell, MD, PhD; Carlos G.ÌýGrijalva, MD, MPH; Adrienne Baughman, BS; Kelsey N.ÌýWomack, PhD; Sydney A.ÌýSwan, MPH; Cassandra A.ÌýJohnson, MS; Cara T.ÌýLwin, BS; Nathaniel M.ÌýLewis, PhD; Sascha Ellington, PhD, MSPH; Meredith L.ÌýMcMorrow, MD, MPH; Emily T.ÌýMartin, PhD; Wesley H.ÌýSelf, MD, MPH; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network
open access
ÁñÁ«ÊÓƵ Netw Open. 2024; 7(4):e244954. 10.1001/jamanetworkopen.2024.4954
This cohort study examines disease severity among adults hospitalized with respiratory syncytial virus (RSV) and compares it with the severity of COVID-19 and influenza by vaccination status.
JAMA
Viewpoint
April 11, 2024
Fatimah S.ÌýDawood, MD; Amanda B.ÌýPayne, PhD; Meredith L.ÌýMcMorrow, MD, MPH
online first
JAMA. 2024; 10.1001/jama.2024.5859
This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.